Financial Performance - The company's revenue for Q1 2021 was ¥159,012,462.67, representing a 0.73% increase compared to ¥157,856,922.15 in the same period last year[9] - Net profit attributable to shareholders decreased by 86.31% to ¥3,789,913.09 from ¥27,693,911.54 year-on-year[9] - The net profit after deducting non-recurring gains and losses fell by 87.75% to ¥3,427,166.39 compared to ¥27,972,159.53 in the previous year[9] - Basic and diluted earnings per share both decreased by 86.00% to ¥0.007 from ¥0.050 year-on-year[9] - The net profit for the reporting period was ¥3,789,913.09, a decrease of 86.30% year-on-year, primarily due to a decline in the sales price of main products and a reduction in gross margin[19] - The total profit for the reporting period was ¥3,398,077.19, a decrease of 89.27% year-on-year, attributed to lower sales prices of main products[19] - The total operating revenue for Q1 2021 was CNY 159,012,462.67, a slight increase from CNY 157,856,922.15 in the same period last year, representing a growth of approximately 0.73%[48] - The net profit for Q1 2021 was CNY 3,789,913.09, a significant decrease from CNY 27,655,661.41 in Q1 2020, reflecting a decline of approximately 86.29%[50] Cash Flow - The net cash flow from operating activities improved significantly to ¥8,895,663.30, a turnaround from a negative cash flow of ¥137,441,984.35 in the same period last year, marking a 106.47% increase[9] - Operating cash flow net amount was ¥8,895,663.30, an increase of 106.47% compared to the same period last year, mainly due to reduced tax payments[19] - The net cash flow from operating activities was approximately ¥8.90 million, a recovery from a negative cash flow of ¥137.44 million in the same period last year[58] - The total cash inflow from operating activities decreased to 238,831,649.06 from 443,507,063.59, representing a decline of approximately 46.1%[61] - Cash outflow from operating activities also decreased to 229,938,146.06 from 580,461,057.47, a reduction of about 60.4%[61] Assets and Liabilities - The total assets at the end of the reporting period were ¥1,624,695,410.53, an increase of 1.74% from ¥1,596,913,103.91 at the end of the previous year[9] - The company's total assets amounted to CNY 1,624,695,410.53, an increase from CNY 1,596,913,103.91 as of December 31, 2020, reflecting a growth of approximately 1.5%[40] - The company's current assets totaled CNY 1,042,626,817.62, slightly up from CNY 1,036,959,642.65 at the end of 2020, indicating a marginal increase of about 0.7%[40] - The company's total liabilities were reported at CNY 139,110,837.82, compared to CNY 115,758,337.44 at the end of 2020, reflecting an increase of about 20.1%[42] - The total liabilities as of March 31, 2021, were CNY 139,106,444.38, up from CNY 115,753,944.00 at the end of 2020, representing an increase of approximately 20.14%[46] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 29,773[11] - The largest shareholder, Zhu Shouchan, holds 39.14% of the shares, totaling 215,768,643 shares[11] - The company has not seen any share reduction from a major shareholder despite a planned reduction announced earlier[26] Investment and R&D - The company plans to enhance product research and development and technology innovation to strengthen its competitive advantage[23] - The company plans to increase R&D investment and optimize product structure to enhance market competitiveness amid uncertainties caused by the COVID-19 pandemic[24] - The company will invest RMB 130 million in its wholly-owned subsidiary, Cangzhou Jianxin Ruixiang Chemical Technology Co., Ltd., to strengthen its capital base[27] - Cangzhou Jianxin successfully acquired land use rights for RMB 142.13 million, enhancing its operational capacity[28] Risks and Challenges - The company is facing risks related to talent shortages, particularly in high-quality technical and management personnel, which may hinder future development[24] - The company is closely monitoring foreign exchange fluctuations to minimize the impact of currency risk on its export business[24] - The company is committed to increasing environmental protection investments to meet stricter regulatory standards in the fine chemical industry[25] - The company has established comprehensive safety production regulations to mitigate risks associated with the use of flammable and explosive chemicals[25] Other Financial Information - The cash flow from investment activities was -¥158,050,816.58, a decrease of 320.90% year-on-year, mainly due to increased cash payments for land use rights[19] - The company reported a financial income of CNY 4,164,626.09, down from CNY 6,595,172.08 in the previous year, a decrease of about 36.93%[49] - The company incurred a credit impairment loss of approximately ¥1.16 million, compared to ¥0.94 million in the previous year[54] - The company did not undergo an audit for the first quarter report[63] - The company implemented new leasing standards starting in 2021, but it is not applicable for retrospective adjustments[63]

Financial Performance - The overall production and sales volume of major products increased in 2020, but due to significant declines in sales prices, gross profit margins decreased, leading to a notable reduction in sales revenue and net profit compared to the previous year[6]. - The company's operating revenue for 2020 was ¥563,706,641.61, a decrease of 39.07% compared to ¥925,158,518.22 in 2019[23]. - The net profit attributable to shareholders in 2020 was ¥45,407,995.41, down 86.05% from ¥325,577,386.27 in 2019[23]. - The net cash flow from operating activities was ¥280,205,960.83, a decline of 27.24% compared to ¥385,097,160.00 in 2019[23]. - The total assets at the end of 2020 were ¥1,596,913,103.91, a decrease of 14.11% from ¥1,859,328,958.49 at the end of 2019[23]. - The net assets attributable to shareholders decreased by 15.50% to ¥1,481,154,766.47 at the end of 2020 from ¥1,752,835,971.07 at the end of 2019[23]. - The basic earnings per share for 2020 was ¥0.0826, down 86.08% from ¥0.5932 in 2019[23]. - The diluted earnings per share for 2020 was ¥0.0825, a decrease of 85.94% compared to ¥0.5867 in 2019[23]. - The weighted average return on equity was 2.91% in 2020, down from 19.87% in 2019, a decline of 16.96%[23]. - The total profit for 2020 was CNY 50.18 million, down 86.74% year-on-year[48]. - The company’s revenue from other operating income was reported at -9,294,842.60, indicating a loss in this category[30]. Research and Development - The company plans to increase R&D investment to enrich product varieties and optimize product structure, aiming to enhance product competitiveness through technological advancements[6]. - The company has established a mature and efficient R&D innovation system, focusing on new product development and environmental improvements[52]. - The company has implemented automation upgrades in key projects, significantly improving production efficiency and reducing costs[50]. - The company has established partnerships with institutions like Tsinghua University to enhance R&D capabilities and drive innovation[48]. - The number of R&D personnel increased to 141, accounting for 15.75% of the total workforce[74]. - In 2020, the company's R&D investment amounted to CNY 24.82 million, representing 4.4% of total revenue[74]. - Research and development expenses decreased by 34.10% to ¥24.82 million, primarily due to reduced investment in R&D activities[73]. Market Strategy and Operations - The company is actively monitoring national industrial policies to adjust its development strategy in response to macroeconomic risks, including the impacts of the COVID-19 pandemic and the complexity of the US-China trade war[7]. - The company aims to improve management levels and enhance R&D capabilities to increase market share and safeguard profitability amid uncertainties in customer production due to the pandemic[7]. - The company plans to increase investment in the composite materials sector, focusing on research and development to enhance market share[34]. - The company’s main business includes the production and sales of benzene-based intermediates, with products used in pharmaceuticals, pesticides, dyes, and paper chemicals[33]. - The company has established long-term stable partnerships with global chemical giants, with products sold in over 20 countries and regions[33]. - The company’s sales model is primarily direct sales, supported by a professional sales team of 20 and a service team of 30[38]. - The company is focusing on expanding its market share through strategic investments in new technologies and product development[85]. Environmental and Safety Measures - The company is focused on environmental protection and plans to increase investment in environmental governance to meet stricter regulatory standards[9]. - The company is committed to enhancing safety production measures and reducing risks associated with the handling of flammable and explosive chemicals[10]. - The company has developed a complete set of wastewater treatment facilities, achieving 80% resource reuse of industrial wastewater[45]. - The company has implemented strict environmental protection measures during project construction, ensuring that pollution control facilities are installed and operated in accordance with environmental assessments[175]. - The company has established a quarterly monitoring program for emissions, including online detection devices for COD and ammonia nitrogen at wastewater discharge points[175]. - The company has maintained a 100% certification rate for special operations personnel, ensuring compliance with safety regulations[172]. - The company has established a comprehensive safety management system, achieving zero major safety incidents during the reporting period[172]. Financial Management and Investments - The company completed a capital increase to support long-term funding needs, enhancing its financial stability[85]. - The company has committed to invest in projects with a total funding of 27,173.5 million CNY, achieving 99.98% of the planned investment[95]. - The company has excess raised funds of RMB 332.33 million, with RMB 30 million allocated for permanent working capital[90]. - The company has approved the use of up to CNY 110 million of temporarily idle excess funds for cash management[101]. - The company has entrusted 226.4 million RMB in bank wealth management products during the reporting period, with no overdue amounts[160]. - The company has not reported any major changes or risks related to its contracts or financial management during the reporting period[159]. Shareholder and Dividend Information - The profit distribution plan approved by the board is to distribute a cash dividend of 1 RMB per 10 shares (including tax) based on a total of 551,249,622 shares[10]. - The cash dividend amount distributed in 2020 accounted for 100% of the distributable profit of 580,666,485.26 yuan[128]. - The cash dividend payout ratio for 2020 was 121.40% of the net profit attributable to ordinary shareholders[130]. - The company has established a cash dividend policy that complies with its articles of association and shareholder resolutions[126]. - The company is in a growth phase and has significant capital expenditure plans, maintaining a minimum cash dividend ratio of 20%[126]. Corporate Governance and Compliance - The company has a comprehensive internal governance structure and has strengthened budget management and cost control measures[52]. - The company has made commitments to avoid conflicts of interest and has adhered to these commitments during the reporting period[131]. - The company has appointed Zhongshen Zhonghuan Accounting Firm (Special General Partnership) for auditing services, with a fee of 390,000 RMB and a continuous service period of 2 years[136]. - There are no significant litigation or arbitration matters reported for the year[138]. - The company has not faced any penalties or rectification issues during the reporting period[139]. Social Responsibility - The company reported a comprehensive commitment to social responsibility, integrating economic development with stakeholder interests, including environmental protection and employee rights[167]. - The company donated ¥800,000 to support COVID-19 prevention efforts, demonstrating its commitment to social responsibility[53]. - The company has not initiated any targeted poverty alleviation programs during the reporting year[173].

河北建新化工股份有限公司 2020 年第三季度报告全文 河北建新化工股份有限公司 2020 年第三季度报告 2020-060 2020 年 10 月 1 河北建新化工股份有限公司 2020 年第三季度报告全文 第一节 重要提示 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真 实、准确、完整，不存在虚假记载、误导性陈述或者重大遗漏，并承担个别和 连带的法律责任。 所有董事均已出席了审议本次季报的董事会会议。 公司负责人朱守琛、主管会计工作负责人高辉及会计机构负责人(会计主管 人员)高辉声明：保证季度报告中财务报表的真实、准确、完整。 2 河北建新化工股份有限公司 2020 年第三季度报告全文 第二节 公司基本情况 一、主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 河北建新化工股份有限公司 2020 年第三季度报告全文 说明原因 □ 适用 √ 不适用 □ 是 √ 否 | | 本报告期末 | 上年度末 | | 本报告期末比上年度末增 | | --- | --- | --- | --- | --- | | | | | | 减 | | 总资产（元） | 1,637,313,512. ...

Financial Performance - The company's operating revenue for the first half of 2020 was CNY 308,454,301.76, a decrease of 42.22% compared to CNY 533,832,641.32 in the same period last year[20]. - The net profit attributable to shareholders of the listed company was CNY 55,236,843.39, down 73.77% from CNY 210,612,228.44 year-on-year[20]. - The basic earnings per share decreased to CNY 0.1005, down 73.80% from CNY 0.3836 in the same period last year[20]. - The total profit for the period was CNY 63.51 million, down 73.79% year-on-year, while the net profit attributable to shareholders was CNY 55.24 million, a decline of 73.77%[37]. - The company reported a significant reduction in undistributed profits from CNY 869,109,488.34 to CNY 594,575,218.53, a decrease of about 31.6%[145]. - The net profit margin for the first half of 2020 was reported at 13.2%, indicating a decline from the previous year's performance[176]. Cash Flow and Investments - The net cash flow from operating activities increased significantly to CNY 99,378,118.36, a rise of 1,711.63% compared to CNY 5,485,563.59 in the previous year[20]. - The company achieved a significant increase in cash flow from operating activities, which rose by 1,711.63% to CNY 99.38 million due to reduced tax payments and lower cash outflows for raw materials[37]. - Cash and cash equivalents at the end of the reporting period amounted to CNY 859.20 million, representing 52.83% of total assets, an increase from 46.91% in the previous year[41]. - The company reported a net cash flow from financing activities of -¥333,730,901.34, worsening from -¥172,919,057.08 in the prior year, primarily due to increased dividend payments[165]. - The company utilized RMB 33.23 million of over-raised funds, with RMB 30 million allocated for permanent working capital[50]. Assets and Liabilities - Total assets at the end of the reporting period were CNY 1,626,458,341.34, a decrease of 12.52% from CNY 1,859,328,958.49 at the end of the previous year[20]. - The total assets at the end of the reporting period amounted to 3,607.9 million, reflecting a stable financial position[173]. - Current liabilities increased from CNY 75,741,456.74 to CNY 111,846,686.67, marking a rise of about 47.8%[144]. - The company’s total liabilities increased from CNY 94,418,428.64 to CNY 134,728,009.55, an increase of about 42.7%[144]. Research and Development - The company has a strong focus on technological innovation, holding 10 invention patents and 18 utility models, which contribute to its competitive edge in the market[30]. - Research and development expenses decreased by 33.61% to CNY 15.53 million, reflecting a reduction in R&D investment during the period[37]. - The company plans to enhance its R&D capabilities and optimize product structure to improve market competitiveness and safeguard profitability[76]. Market Position and Strategy - The company holds the number one global market share for five of its products, including aniline-2,5-disulfonic acid monosodium salt and meta-aminobenzenesulfonic acid, establishing itself as a standard setter in the industry[28]. - The company has established long-term partnerships with major international chemical companies such as BASF and Bayer, enhancing its market presence in over 20 countries and regions[28]. - The company plans to expand its market presence through strategic investments and partnerships in the chemical industry[44]. Environmental and Safety Measures - The company has implemented an advanced wastewater treatment system that recycles 80% of industrial wastewater, ensuring compliance with national environmental regulations[31]. - Environmental regulations are becoming stricter, and the company is committed to increasing investment in environmental protection to meet these standards[78]. - The company has installed monitoring devices for COD and ammonia nitrogen at wastewater discharge points, ensuring real-time monitoring of emissions[113]. Risks and Challenges - The company faced risks from the COVID-19 pandemic, which affected production and sales, leading to potential underperformance in sales volume[76]. - The company is addressing the risk of talent shortages by establishing a talent cultivation and innovation incentive mechanism[77]. - The company is monitoring foreign exchange fluctuations due to a significant portion of its exports being settled in USD, which poses a currency risk[77]. Shareholder and Corporate Governance - The company plans not to distribute cash dividends or issue bonus shares during this reporting period[6]. - The company has committed to avoiding competition with its own shareholders and is currently in compliance with this commitment[84]. - The company did not engage in any investor relations activities during the reporting period[79]. Miscellaneous - The company has not made any changes to its registered information or contact details during the reporting period[19]. - The company has not reported any ongoing litigation related to its investments[44]. - The company has not experienced any penalties or rectification issues during the reporting period[90].

Financial Performance - Total revenue for Q1 2020 was ¥157,856,922.15, a decrease of 46.27% compared to ¥293,815,663.51 in the same period last year[9] - Net profit attributable to shareholders was ¥27,693,911.54, down 74.49% from ¥108,575,879.86 year-on-year[9] - Basic earnings per share decreased by 74.75% to ¥0.050 from ¥0.198 in the previous year[9] - The company's operating revenue for Q1 2020 was CNY 157,856,922.15, a decrease of 46.27% compared to the same period last year[21] - The net profit attributable to shareholders for Q1 2020 was CNY 2,769,390.00, down 74.49% year-on-year[24] - The company's net profit is expected to decline by 50% to 80% compared to the same period last year due to a significant decrease in sales prices and revenue[42] - The total profit for Q1 2020 was ¥31,669,996.54, a decline of 74.9% from ¥126,220,836.89 in Q1 2019[60] Cash Flow and Assets - Net cash flow from operating activities was negative at ¥137,441,984.35, a decline of 459.00% compared to ¥38,285,162.89 in the same period last year[9] - Cash and cash equivalents increased to ¥1,057,268,479.71 from ¥983,783,379.27, reflecting a growth of 7.5%[52] - Total assets at the end of the reporting period were ¥1,899,485,645.59, an increase of 2.16% from ¥1,859,328,958.49 at the end of the previous year[9] - The total assets of the company stood at 1,859,328,958.49 yuan, reflecting the company's financial position[74] - The company reported a significant increase in cash outflow related to operating activities, totaling 580,461,057.47 yuan, compared to 455,638,923.99 yuan last year[70] Shareholder Information - The company reported a total of 35,424 common shareholders at the end of the reporting period[13] - The largest shareholder, Zhu Shouchan, holds 39.26% of the shares, totaling 215,768,643 shares[13] Research and Development - The company's R&D expenses for Q1 2020 were CNY 6,899,628.17, a decrease of 40.62% compared to the previous year[21] - Research and development expenses for Q1 2020 were ¥6,899,628.17, a decrease of 40.3% compared to ¥11,619,190.05 in Q1 2019[58] - The company plans to enhance its R&D capabilities by investing in a new R&D center and advancing the construction of a new materials manufacturing base[25] - The company plans to enhance its R&D capabilities and optimize product structure to improve market competitiveness[29] Investments and Projects - The company has committed to projects with a total investment of CNY 27,173 million, achieving a completion rate of 99.99%[37] - New projects include an annual production capacity of 16,000 tons of aminobenzenesulfonic acid and a 1,200 tons/year hydrogenation reduction project[38] - The company has invested CNY 2,500 million in a new evaporation and MVR supporting facility, achieving a completion rate of 60.88%[38] - The company has allocated CNY 3,000 million for working capital, fully utilized[38] Financial Management - The company has implemented strict management of raised funds, ensuring effective use and cost control[42] - The company has not implemented any share buyback plans during the reporting period[34] - No overdue commitments were reported by the actual controller, shareholders, or related parties during the reporting period[35] Regulatory and Compliance - The company has committed to increasing environmental protection investments to meet stricter regulatory standards[30] - The company has begun implementing new revenue and leasing standards from January 1, 2020, affecting the presentation of financial statements[75] - The company adopted new revenue recognition standards starting January 1, 2020, impacting the classification of contract liabilities[78] Market Strategy - The company aims to expand its domestic and international market presence to increase profitability[29] - The company is addressing talent shortages by establishing a talent development and innovation incentive mechanism[29] - The company plans to continue monitoring market conditions and adjust strategies accordingly to mitigate risks[42]

Financial Performance - The company's operating revenue for 2019 was ¥925,158,518.22, a decrease of 34.77% compared to ¥1,418,294,158.04 in 2018[21]. - The net profit attributable to shareholders for 2019 was ¥325,577,386.27, down 50.37% from ¥656,013,995.26 in 2018[21]. - The net cash flow from operating activities increased by 27.55% to ¥385,097,160.00 in 2019, compared to ¥301,907,378.14 in 2018[21]. - The total assets at the end of 2019 were ¥1,859,328,958.49, reflecting a 7.40% increase from ¥1,731,222,160.26 at the end of 2018[21]. - The company's basic earnings per share for 2019 was ¥0.5932, a decline of 50.55% from ¥1.1996 in 2018[21]. - The weighted average return on equity for 2019 was 19.87%, down 32.15% from 52.02% in 2018[21]. - During the reporting period, the company's revenue was CNY 92,515.85 million, a decrease of 34.77% year-on-year; total profit was CNY 37,829.23 million, down 50.58%; and net profit attributable to shareholders was CNY 32,557.74 million, a decline of 50.37%[38]. - The company reported a total revenue of 1,616 million CNY for the year 2019, representing a year-on-year increase of 22.4%[138]. - The net profit attributable to shareholders was 122 million CNY, with a profit margin of 6.80%[138]. - The gross profit margin for the year was reported at 22.4%, indicating strong operational efficiency[138]. Market Strategy and Expansion - The company plans to expand its domestic and international markets to increase its customer base and profitability[5]. - The company is focusing on expanding its existing industries and leveraging the advantages of the Cangzhou Lingang Economic and Technological Development Zone for faster development[93]. - The company is actively pursuing market expansion strategies, targeting both domestic and international markets to increase its footprint[178]. - The company plans to invest in new product development, focusing on innovative chemical solutions to enhance market competitiveness[178]. - Future guidance suggests a projected revenue growth of 10% for the upcoming fiscal year[139]. - The company is exploring potential mergers and acquisitions to strengthen its market position and diversify its product offerings[139]. Research and Development - The company aims to enhance product development and technological innovation, focusing on the industrial application of micro-reactor technology in the aminobenzenesulfonic acid process[95]. - The company is committed to establishing a new research and development center to facilitate advanced composite materials research and large-scale industrialization[94]. - The company has a total of 9 invention patents, 11 utility models, and 35 proprietary technologies, forming a core technology system with independent intellectual property rights[35]. - The company has strengthened its research and development capabilities, with multiple environmental technologies becoming core competitive advantages[43]. - R&D investment in 2019 amounted to ¥37,663,753.74, representing 4.07% of operating revenue, an increase from 3.49% in 2018[62]. - The number of R&D personnel increased to 131 in 2019, accounting for 15.39% of the total workforce[62]. Environmental and Safety Initiatives - The company is committed to increasing environmental protection investments to meet stricter regulatory standards[7]. - The company recognizes the potential impact of environmental regulations on its operations and is dedicated to improving its overall environmental awareness[7]. - The company has developed a complete set of wastewater treatment facilities that achieve 80% resource reuse of industrial wastewater, ensuring sustainable development[36]. - The company has increased investment in safety and environmental protection measures, utilizing self-owned funds for significant upgrades and technological improvements[95]. - The company has implemented pollution prevention facilities during project construction, ensuring compliance with environmental standards through detailed operational procedures[149]. - The company has established an emergency response plan for environmental incidents, which was revised and filed with the local ecological environment bureau[150]. Talent and Management - The company emphasizes the importance of attracting and cultivating high-quality technical and management talent to support its growth[6]. - The company has implemented a stock incentive plan to align employee goals with long-term corporate development, enhancing cohesion and morale[41]. - The company has a structured approach to performance-based remuneration for its executives, aligning incentives with company performance[188]. - The total remuneration for the board of directors, supervisors, and senior management during the reporting period was fully paid according to the established standards[188]. - The company’s management team includes experienced professionals with backgrounds in finance, engineering, and law, ensuring a diverse skill set[186]. Financial Management and Governance - The company has maintained compliance with the Shenzhen Stock Exchange's regulations throughout the reporting period[185]. - The company’s financial director has over 20 years of experience in auditing and financial management, contributing to the company's financial stability[187]. - The company has a strong focus on independent operations, with no interference from the controlling shareholder in decision-making processes[199]. - The company has not reported any major contracts or management issues during the reporting period, ensuring smooth operational continuity[132]. - The company has not faced any penalties from the China Securities Regulatory Commission or other relevant authorities during the reporting period[185]. Shareholder and Equity Information - The company reported a profit distribution plan of 6 RMB per 10 shares (including tax) based on a total of 549,618,522 shares[8]. - The cash dividend for 2019 represents 100% of the total profit distribution, indicating a strong commitment to returning value to shareholders[104]. - The largest shareholder, Zhu Shouchan, holds 39.26% of the company, equating to 215,768,643 shares[164]. - The company has a total of 215,698,562 restricted shares, with 76,250 shares released from restrictions during the reporting period[160]. - The company has not implemented any share buyback or reduction during the reporting period[158]. Community Engagement and Corporate Social Responsibility - The company has actively contributed to local community projects, including public lighting and road repairs[145]. - The company emphasizes transparency and communication with investors through various platforms[144]. - The company has not initiated any targeted poverty alleviation programs in the reporting year[146].

Financial Performance - Net profit attributable to shareholders was ¥71,507,876.37, a decrease of 65.98% year-on-year[8]. - Operating revenue for the period was ¥210,567,773.29, down 49.01% compared to the same period last year[8]. - Basic earnings per share were ¥0.130, reflecting a decline of 66.15% year-on-year[8]. - The weighted average return on net assets was 4.28%, a decrease of 11.97% compared to the previous year[8]. - Cash flow from operating activities for the year-to-date was ¥58,190,060.08, down 86.96% year-on-year[8]. - Net profit after deducting non-recurring gains and losses was ¥69,580,878.68, a decrease of 66.13% year-on-year[8]. - The total profit for the period was ¥328,458,605.86, a decrease of 43.05% year-on-year, primarily due to lower sales prices and reduced sales revenue[21]. - Basic and diluted earnings per share were ¥0.513, a decrease of 43.19% year-on-year, attributed to the reduction in profit[22]. - The operating profit for the period was CNY 329,462,088.18, a decrease of 44.3% from CNY 589,928,287.63 in the previous period[54]. - The total comprehensive income for the period was CNY 282,120,104.81, compared to CNY 493,575,392.24 in the previous period, indicating a decrease[58]. Assets and Liabilities - Total assets at the end of the reporting period reached ¥1,809,016,884.53, an increase of 4.49% compared to the previous year[8]. - The cash balance at the end of the period was ¥934,512,917.50, an increase of 41.82% compared to the beginning of the period, mainly due to increased collection of acceptance bills and a decrease in financial investments[19]. - Total current assets amounted to CNY 1,335,937,507.23, an increase from CNY 1,265,292,989.90 as of December 31, 2018, representing a growth of approximately 5.3%[35]. - Total liabilities decreased to CNY 97,895,140.74 from CNY 154,673,211.53, reflecting a decline of about 36.7%[37]. - Owner's equity increased to CNY 1,711,121,743.79 from CNY 1,576,548,948.73, representing a growth of approximately 8.5%[38]. - Total non-current assets increased to CNY 473,079,377.30 from CNY 465,929,170.36, showing a growth of approximately 1.6%[36]. - Total current liabilities decreased to CNY 81,392,802.29 from CNY 145,162,648.38, a significant reduction of approximately 44%[37]. Shareholder Information - The company reported a total of 39,204 common shareholders at the end of the reporting period[12]. - The largest shareholder, Zhu Shouchan, holds 39.26% of the shares, totaling 215,768,643 shares[12]. - The company did not engage in any repurchase transactions during the reporting period[13]. Cash Flow - Net cash flow from operating activities decreased to CNY 58,190,060.08 from CNY 446,279,032.87, a decline of approximately 87.0%[61]. - Cash inflow from operating activities totaled CNY 999,122,373.34, an increase from CNY 773,986,056.03 in the previous period, representing a growth of about 28.9%[60]. - Cash inflow from investment activities was CNY 345,172,815.23, down from CNY 875,341,080.45, indicating a decrease of about 60.5%[65]. - The net cash flow from investment activities improved to CNY 95,560,102.05 from a negative CNY 249,251,087.95, showing a significant recovery[65]. - Cash inflow from financing activities was CNY 93,280,130.71, compared to CNY 3,386,908.46 in the previous period, marking a substantial increase[62]. Research and Development - Research and development expenses for Q3 2019 were ¥9,366,776.32, an increase of 13.6% compared to ¥8,242,453.91 in Q3 2018[45]. - Research and development expenses amounted to CNY 32,750,085.68, a decrease of 6.7% from CNY 35,099,225.96 in the previous period[52]. Financial Management - The company has implemented new financial and revenue recognition standards starting from 2019, impacting financial reporting[66]. - The company has committed to not providing financial assistance or guarantees to incentive targets as per its equity incentive management regulations[29]. - There were no violations regarding external guarantees during the reporting period[30]. - The company reported no non-operating fund occupation by controlling shareholders or related parties during the reporting period[31]. - The company has not executed any cash dividend policy during the reporting period[30].

Financial Performance - Total revenue for the first half of 2019 was CNY 533.83 million, a decrease of 16.93% compared to CNY 642.64 million in the same period last year[20]. - Net profit attributable to shareholders was CNY 210.61 million, down 25.68% from CNY 283.37 million year-on-year[20]. - Basic earnings per share decreased to CNY 0.3836, down 25.99% from CNY 0.5183 in the same period last year[20]. - Weighted average return on equity was 12.92%, down 12.28% from 25.20% in the previous year[20]. - The total profit for the period was CNY 242.33 million, down 26.75% year-on-year, while the net profit attributable to shareholders was CNY 210.61 million, a decline of 25.68%[41]. - The gross profit margin for ODB-2 was 57.80%, down 10.51% year-on-year, while for meta-aminophenol it was 58.47%, down 8.25% year-on-year[43]. - The company reported a net profit margin of 2.90%, showing a significant improvement compared to the previous year[67]. - The company achieved a return on equity of 8.85% in the first half of 2019, indicating strong financial performance[67]. - The gross profit margin improved to 6.80% in the first half of 2019, up from 5.96% in the same period last year[67]. Cash Flow and Investments - Net cash flow from operating activities was CNY 5.49 million, a significant decline of 97.95% compared to CNY 267.22 million in the previous year[20]. - The company's cash and cash equivalents net decrease was CNY 68.20 million, a 206.64% increase in loss compared to the previous year[41]. - The company achieved a significant increase in cash flow from investing activities, with a net inflow of CNY 99.57 million, a 147.13% improvement year-on-year[41]. - The company reported a net cash outflow from financing activities of approximately ¥172.92 million in the first half of 2019, compared to a net outflow of ¥79.39 million in the same period of 2018[155]. - The total cash inflow from investment activities was CNY 312,872,289.10, down from CNY 523,638,529.55, resulting in a net cash flow from investment activities of CNY 99,566,102.84, compared to a negative CNY 211,257,821.29 last year[158]. Assets and Liabilities - Total assets at the end of the reporting period were CNY 1.75 billion, an increase of 1.06% from CNY 1.73 billion at the end of the previous year[20]. - The total liabilities decreased to CNY 115,883,250.50 from CNY 154,673,211.53, indicating a reduction of about 25.1%[137]. - The company's equity attributable to shareholders increased to CNY 1,633,607,607.49 from CNY 1,576,548,948.73, reflecting a growth of approximately 3.6%[137]. - The total current assets as of June 30, 2019, amounted to CNY 1,277,065,178.94, an increase from CNY 1,265,292,989.90 at the end of 2018[134]. - The inventory decreased to CNY 96,381,288.30 from CNY 106,774,151.04, a decline of about 9.7%[135]. Research and Development - Research and development investment decreased by 23.60% to CNY 23.38 million during the reporting period[41]. - Research and development expenses for the first half of 2019 were CNY 23,383,309.36, down 23.8% from CNY 30,607,030.28 in the first half of 2018[145]. - The company is focusing on enhancing its research and development capabilities to innovate new technologies and products[165]. Market Position and Strategy - The company is focusing on the development of new products and technologies to enhance its market position[20]. - The company has developed a unique "one chain three bodies" business structure, focusing on high-end products and downstream market expansion[31]. - The company is exploring potential mergers and acquisitions to enhance its competitive position in the market[66]. - Future guidance suggests a projected revenue growth of 20% for the next fiscal year, driven by new product launches and market expansion efforts[66]. Shareholder Information - The company plans not to distribute cash dividends or issue bonus shares for this reporting period[6]. - The annual shareholders meeting had a participation rate of 52.08%[80]. - The largest shareholder, Zhu Shouchan, holds 39.30% of the shares, totaling 215,768,634 shares[118]. - The total number of ordinary shareholders at the end of the reporting period is 41,718[118]. Risk Management - The company has detailed the risks it faces and corresponding countermeasures in the management discussion section of the report[5]. - The company faces market risks due to potential impacts from the US-China trade dispute, which may affect export volumes[76]. - The company is exposed to exchange rate risks due to a significant portion of its exports being settled in USD, and it plans to utilize foreign exchange hedging tools[76]. - The company is addressing the risk of losing core technical personnel by implementing effective internal incentive and reward systems[76]. Environmental and Safety Management - The company maintained a strong focus on safety and environmental management, ensuring compliance with national regulations and achieving zero environmental incidents during the reporting period[37]. - The company’s environmental technology allows for 80% of industrial wastewater to be reused, ensuring sustainable development and industry leadership[33]. - The company is committed to increasing environmental protection investments to meet stricter regulatory standards in the chemical industry[77]. Corporate Governance - The company did not experience any changes in its board of directors or senior management during the reporting period[127]. - The financial report for the first half of 2019 was not audited[132]. - The company has implemented a stock option and restricted stock incentive plan, granting 5.583 million stock options and 1.46 million restricted shares to 111 incentive recipients[90].

证券代码：300107 证券简称：建新股份 公告编号：2019-032 河北建新化工股份有限公司 关于参加河北辖区上市公司 2019 年度投资者网上集体接待 日暨全国投资者保护宣传日活动的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 河北建新化工股份有限公司（以下简称"公司"）定于 2019 年 5 月 15 日（星 期三）下午 15:00-17:00 参加中国证监会河北监管局举办的"河北辖区上市公司 2019 年度投资者网上集体接待日暨全国投资者保护宣传日活动"。现将相关事 项公告如下： 本次活动将在深圳全景网络有限公司提供的网上平台采取网络远程的方式 举 行 ， 投 资 者 可 以 登 录 " 河 北 辖 区 上 市 公 司 投 资 者 关 系 互 动 平 台 （http://rs.p5w.net）参与交流。 届时，公司相关高管人员将针对投资者关心的 2018 年年报、公司治理、发 展战略、经营状况、融资计划、股权激励、可持续发展等问题通过网络在线与投 资者进行沟通与交流，欢迎广大投资者积极参与。 特此公告 河北建新化工股份有限公司 董 事 会 二 ...

Financial Performance - Total revenue for Q1 2019 was CNY 293,815,663.51, an increase of 7.40% compared to CNY 273,581,968.10 in the same period last year[8]. - Net profit attributable to shareholders was CNY 108,575,879.86, a decrease of 4.66% from CNY 113,878,834.32 year-on-year[8]. - Basic earnings per share were CNY 0.198, down 4.81% from CNY 0.208 in the same period last year[8]. - The company's operating revenue for Q1 2019 was CNY 293.82 million, representing a year-on-year increase of 7.40%[21]. - The net profit attributable to shareholders for Q1 2019 was CNY 108.58 million, a decrease of 4.66% compared to the same period last year[21]. - The total operating revenue for Q1 2019 was CNY 293,815,663.51, an increase of 7.5% compared to CNY 273,581,968.10 in the same period last year[51]. - The total operating costs amounted to CNY 168,065,117.55, up 18.8% from CNY 141,479,762.64 in Q1 2018[51]. - The total profit for Q1 2019 was CNY 126,220,836.89, down from CNY 133,442,661.90 in Q1 2018, indicating a decrease of 5.4%[57]. - The operating profit for Q1 2019 was CNY 126,488,155.44, compared to CNY 134,362,538.47 in Q1 2018, reflecting a decline of 5.5%[57]. Cash Flow and Assets - Net cash flow from operating activities decreased by 59.36% to CNY 38,285,162.89 from CNY 94,211,053.34 in the previous year[8]. - Cash and cash equivalents increased by 43.41% from CNY 658.96 million at the beginning of the period to CNY 945.02 million at the end of the period[19]. - The cash flow from operating activities decreased by 59.36% to CNY 38.29 million, mainly due to an increase in bank time deposits[20]. - The net cash flow from operating activities for the first quarter was CNY 38,285,162.89, a decrease of 59.3% compared to CNY 94,211,053.34 in the same period last year[65]. - Total cash inflow from operating activities reached CNY 493,924,086.88, up 146.1% from CNY 200,812,410.38 year-on-year[65]. - Cash outflow from operating activities was CNY 455,638,923.99, an increase of 327.5% compared to CNY 106,601,357.04 in the previous year[65]. - The company's total assets amounted to CNY 1,849,026,455.43, an increase from CNY 1,731,222,160.26 as of December 31, 2018, reflecting a growth of approximately 6.8%[42]. - The company's cash and cash equivalents reached CNY 945,016,905.67, up from CNY 658,960,047.31 at the end of 2018, indicating a significant increase of about 43.4%[42]. - Accounts receivable decreased slightly to CNY 226,266,463.50 from CNY 245,334,030.02, representing a decline of approximately 7.8%[42]. - Inventory levels were reported at CNY 97,920,929.58, down from CNY 106,774,151.04, showing a decrease of about 8.3%[42]. Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 46,058[12]. - The largest shareholder, Zhu Shouchan, holds 39.32% of the shares, totaling 215,768,643 shares[12]. - No overdue commitments were reported by the actual controller, shareholders, or related parties during the reporting period[30]. - The company has not implemented any share buyback plans during the reporting period[29]. - The company’s major shareholders have not executed their share reduction plans as previously announced[26]. Investment and R&D - Research and development expenses rose by 63.42% to CNY 116.19 million, indicating increased investment in innovation[19]. - The company is investing in new technologies, including a three-dimensional electrode oxidation technology for high-salinity wastewater treatment with a capacity of 700m3/d[33]. - The company has invested in a research and development center to support its ongoing innovation efforts[33]. - The company plans to enhance its management level and increase R&D investment to improve product competitiveness and expand overseas markets[23]. Risks and Compliance - The company faces macroeconomic risks, including potential impacts from international market demand and domestic environmental policies[23]. - The company is addressing the risk of talent shortages by establishing a comprehensive talent cultivation and incentive mechanism[24]. - The company is facing environmental risks due to stricter regulations in the fine chemical industry, which may impact production and profitability if compliance is not met[25]. - Safety production risks are present due to the use of flammable and explosive chemicals, prompting the company to enhance safety measures and employee training[25]. - The company continues to monitor and adapt to safety and environmental regulations to mitigate risks[25]. Financial Management - The company has not disclosed any issues regarding the use of raised funds or their whereabouts, with all unused funds stored in a dedicated account[36]. - The company has approved the use of up to 11 million CNY of idle oversubscribed funds for cash management[34]. - The company has continued to use 6 million CNY of idle oversubscribed funds for cash management, allowing for rolling use of the funds[34]. - The company invested 4 million CNY in a principal-protected RMB financial product, with a total redemption amount of 40.17 million CNY[34]. - The company achieved an investment return of 398.68 thousand CNY from a financial product redeemed in January 2016[34].